SIRIO (300791.SZ): HKEX Listing Application Lapses; World’s Third-Largest Nutritional Health Food Solution Provider
NewTimeSpace News: Sirio Pharma Co., Ltd. (300791.SZ) submitted its listing application to the Hong Kong Stock Exchange on 29 January 2026. The application has lapsed upon expiry of the six-month term. CICC serves as the original sole sponsor.
The Company is a leading provider of nutritional health food solutions. Per CIC Consulting statistics, based on 2024 revenue, the Company is the world’s third-largest player and China’s top player in the nutritional health food solution market. It is also the world’s second-largest supplier of nutritional health food solutions for soft capsules and gummies, owning over 400 product approvals.
The Company entered the soft capsule nutritional health food market in 1999 as one of the earliest market participants, and tapped into the gummy market starting in 2007. From 2022 to 2024, its soft capsule revenue achieved a compound annual growth rate (CAGR) of 41%, while gummy revenue registered a CAGR of 30%. Its customer base includes numerous well-known brand owners and retailers.
NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Zhongji Innolight Co.,Ltd. (03308.HK) Grey Market Down 2.24% at HK$958
- iWOW Technology Completes Approximately SGD 15 Million Placement to Accelerate Expansion of AgeTech and Clinical Nutrition Businesses
- IPS Securex Holdings: Awarded SGD 1 Million Contract for Data Centre Security Systems
- Keppel REIT to Sell Tokyo KR Ginza II Asset for Approximately JPY 11.52 Billion at a 9.7% Premium